Scholarlink

Benign prostatic hyperplasia (BPH) is a common, age-related non-cancerous enlargement of the prostate causing lower urinary tract symptoms (LUTS). Symptoms are categorized as obstructive (e.g., weak stream, hesitancy) or irritative (e.g., urgency, frequency). The International Prostate Symptom Score (IPSS) aids in assessing severity and treatment need. Investigations help exclude differentials like infection or malignancy. Management depends on symptom severity and impact on quality of life—ranging from lifestyle changes to pharmacotherapy (alpha-blockers, 5-ARIs) and, if needed, surgery. Regular monitoring with IPSS guides ongoing care. No preventive therapy exists, but combination treatment helps slow progression and improve long-term outcome.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Benign Prostatic Hyperplasia

  • 章节

  • 发表日期：

    2025年

查看全文
  • Samuel Wong Leong Kheng,
  • Yogarabindranath Swarna Nantha

摘要

Benign prostatic hyperplasia (BPH) is a common, age-related non-cancerous enlargement of the prostate causing lower urinary tract symptoms (LUTS). Symptoms are categorized as obstructive (e.g., weak stream, hesitancy) or irritative (e.g., urgency, frequency). The International Prostate Symptom Score (IPSS) aids in assessing severity and treatment need. Investigations help exclude differentials like infection or malignancy. Management depends on symptom severity and impact on quality of life—ranging from lifestyle changes to pharmacotherapy (alpha-blockers, 5-ARIs) and, if needed, surgery. Regular monitoring with IPSS guides ongoing care. No preventive therapy exists, but combination treatment helps slow progression and improve long-term outcome.